Dopamine D2 receptor-mediated neuroprotection in a G2019S Lrrk2 genetic model of Parkinson’s disease
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Dopamine D2 receptor-mediated neuroprotection in a G2019S Lrrk2 genetic model of Parkinson’s disease
Authors
Keywords
-
Journal
Cell Death & Disease
Volume 9, Issue 2, Pages -
Publisher
Springer Nature
Online
2018-02-12
DOI
10.1038/s41419-017-0221-2
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Shaping mitochondrial dynamics: The role of cAMP signalling
- (2018) Giulietta Di Benedetto et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Use of luciferase probes to measure ATP in living cells and animals
- (2017) Giampaolo Morciano et al. Nature Protocols
- Water-Soluble Coenzyme Q10 Reduces Rotenone-Induced Mitochondrial Fission
- (2017) Hai-Ning Li et al. NEUROCHEMICAL RESEARCH
- Role of LRRK2 in the regulation of dopamine receptor trafficking
- (2017) Mauro Rassu et al. PLoS One
- Early alterations of mitochondrial morphology in dopaminergic neurons from Parkinson's disease-like pathology and time-dependent neuroprotection with D2 receptor activation
- (2016) Lyle Wiemerslage et al. MITOCHONDRION
- Function and dysfunction of leucine-rich repeat kinase 2 (LRRK2): Parkinson's disease and beyond
- (2015) Jae Ryul Bae et al. BMB Reports
- Defective autophagy is a key feature of cerebral cavernous malformations
- (2015) Saverio Marchi et al. EMBO Molecular Medicine
- Selective expression of Parkinson's disease-relatedLeucine-rich repeat kinase 2G2019S missense mutation in midbrain dopaminergic neurons impairs dopamine release and dopaminergic gene expression
- (2015) Guoxiang Liu et al. HUMAN MOLECULAR GENETICS
- DAT imaging and clinical biomarkers in relatives at genetic risk for LRRK2 R1441G Parkinson's disease
- (2015) Alberto Bergareche et al. MOVEMENT DISORDERS
- Behavioral, neurochemical, and pathologic alterations in bacterial artificial chromosome transgenic G2019S leucine-rich repeated kinase 2 rats
- (2015) Jang-Won Lee et al. NEUROBIOLOGY OF AGING
- An early axonopathy in a hLRRK2(R1441G) transgenic model of Parkinson disease
- (2015) Patricia Tagliaferro et al. NEUROBIOLOGY OF DISEASE
- Progressive dopaminergic alterations and mitochondrial abnormalities in LRRK2 G2019S knock-in mice
- (2015) M. Yue et al. NEUROBIOLOGY OF DISEASE
- Clinical and imaging markers in premotor LRRK2 G2019S mutation carriers
- (2015) Dolores Vilas et al. PARKINSONISM & RELATED DISORDERS
- Role of soluble adenylyl cyclase in mitochondria
- (2014) Federica Valsecchi et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- LRRK2 overexpression alters glutamatergic presynaptic plasticity, striatal dopamine tone, postsynaptic signal transduction, motor activity and memory
- (2014) Dayne A. Beccano-Kelly et al. HUMAN MOLECULAR GENETICS
- Pharmacological Treatment of Parkinson Disease
- (2014) Barbara S. Connolly et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Differential LRRK2 expression in the cortex, striatum, and substantia nigra in transgenic and nontransgenic rodents
- (2014) Andrew B. West et al. JOURNAL OF COMPARATIVE NEUROLOGY
- LRRK2 pathobiology in Parkinson's disease
- (2014) Ian Martin et al. JOURNAL OF NEUROCHEMISTRY
- Direct and indirect pathways of basal ganglia: a critical reappraisal
- (2014) Paolo Calabresi et al. NATURE NEUROSCIENCE
- Conditional expression of Parkinson's disease-related R1441C LRRK2 in midbrain dopaminergic neurons of mice causes nuclear abnormalities without neurodegeneration
- (2014) Elpida Tsika et al. NEUROBIOLOGY OF DISEASE
- Genetic and pharmacological evidence that G2019S LRRK2 confers a hyperkinetic phenotype, resistant to motor decline associated with aging
- (2014) Francesco Longo et al. NEUROBIOLOGY OF DISEASE
- The neuroprotective effect of human uncoupling protein 2 (hUCP2) requires cAMP-dependent protein kinase in a toxin model of Parkinson's disease
- (2014) Ran-Der Hwang et al. NEUROBIOLOGY OF DISEASE
- Chronic ethanol exposure changes dopamine D2 receptor splicing during retinoic acid-induced differentiation of human SH-SY5Y cells
- (2014) Catrin Wernicke et al. Pharmacological Reports
- LRRK2 R1441G mice are more liable to dopamine depletion and locomotor inactivity
- (2014) Hui-Fang Liu et al. Annals of Clinical and Translational Neurology
- Paradoxical Abatement of Striatal Dopaminergic Transmission by Cocaine and Methylphenidate
- (2013) Mauro Federici et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Subcellular calcium measurements in mammalian cells using jellyfish photoprotein aequorin-based probes
- (2013) Massimo Bonora et al. Nature Protocols
- Interferon-β1a protects neurons against mitochondrial toxicity via modulation of STAT1 signaling: Electrophysiological evidence
- (2013) Massimiliano Di Filippo et al. NEUROBIOLOGY OF DISEASE
- Olfaction and imaging biomarkers in premotor LRRK2 G2019S-associated Parkinson disease
- (2013) M. Sierra et al. NEUROLOGY
- Monogenic Parkinson's disease and parkinsonism: Clinical phenotypes and frequencies of known mutations
- (2013) Andreas Puschmann PARKINSONISM & RELATED DISORDERS
- cAMP and Mitochondria
- (2013) Federica Valsecchi et al. PHYSIOLOGY
- LRRK2 Affects Vesicle Trafficking, Neurotransmitter Extracellular Level and Membrane Receptor Localization
- (2013) Rossana Migheli et al. PLoS One
- Mitochondrial Biology and Parkinson's Disease
- (2013) C. Perier et al. Cold Spring Harbor Perspectives in Medicine
- Temporal Expression of Mutant LRRK2 in Adult Rats Impairs Dopamine Reuptake
- (2012) Hongxia Zhou et al. International Journal of Biological Sciences
- Animal models of the non-motor features of Parkinson's disease
- (2012) Kimberly McDowell et al. NEUROBIOLOGY OF DISEASE
- Cyclic AMP is both a pro-apoptotic and anti-apoptotic second messenger
- (2011) P. A. Insel et al. Acta Physiologica
- LRRK2 protein levels are determined by kinase function and are crucial for kidney and lung homeostasis in mice
- (2011) Martin C. Herzig et al. HUMAN MOLECULAR GENETICS
- Clinical and brain imaging characteristics in leucine-rich repeat kinase 2-associated PD and asymptomatic mutation carriers
- (2011) Kathrin Brockmann et al. MOVEMENT DISORDERS
- A tale on animal models of Parkinson's disease
- (2011) Erwan Bezard et al. MOVEMENT DISORDERS
- Neuroprotective Role of Dopamine Agonists
- (2011) Maria Trinidad Herrero et al. NEUROLOGIST
- Mouse models for LRRK2 Parkinson's disease
- (2011) Qing Xu et al. PARKINSONISM & RELATED DISORDERS
- Dopaminergic Neuronal Loss, Reduced Neurite Complexity and Autophagic Abnormalities in Transgenic Mice Expressing G2019S Mutant LRRK2
- (2011) David Ramonet et al. PLoS One
- Gene–environment interactions: Key to unraveling the mystery of Parkinson's disease
- (2011) Hui-Ming Gao et al. PROGRESS IN NEUROBIOLOGY
- Enhanced Striatal Dopamine Transmission and Motor Performance with LRRK2 Overexpression in Mice Is Eliminated by Familial Parkinson's Disease Mutation G2019S
- (2010) X. Li et al. JOURNAL OF NEUROSCIENCE
- Impaired dopaminergic neurotransmission and microtubule-associated protein tau alterations in human LRRK2 transgenic mice
- (2010) H.L. Melrose et al. NEUROBIOLOGY OF DISEASE
- Mitochondrial impairment in patients with Parkinson disease with the G2019S mutation in LRRK2
- (2010) H. Mortiboys et al. NEUROLOGY
- Loss of leucine-rich repeat kinase 2 causes impairment of protein degradation pathways, accumulation of -synuclein, and apoptotic cell death in aged mice
- (2010) Y. Tong et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Mitochondria-targeted antioxidant effects of S(-) and R(+) pramipexole
- (2010) Giulia Ferrari-Toninelli et al. BMC Pharmacology & Toxicology
- Occupation and Risk of Parkinsonism
- (2009) Caroline M. Tanner et al. ARCHIVES OF NEUROLOGY
- Downstream mechanisms triggered by mitochondrial dysfunction in the basal ganglia: From experimental models to neurodegenerative diseases
- (2009) Paolo Gubellini et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- LRRK2 Modulates Vulnerability to Mitochondrial Dysfunction in Caenorhabditis elegans
- (2009) S. Saha et al. JOURNAL OF NEUROSCIENCE
- Mutant LRRK2 R1441G BAC transgenic mice recapitulate cardinal features of Parkinson's disease
- (2009) Yanping Li et al. NATURE NEUROSCIENCE
- Environmental toxins and Parkinson's disease: what have we learned from pesticide-induced animal models?
- (2009) Francesca Cicchetti et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- D2/D3 receptor agonist ropinirole protects dopaminergic cell line against rotenone-induced apoptosis through inhibition of caspase- and JNK-dependent pathways
- (2008) Sheng Chen et al. FEBS LETTERS
- Electrophysiology and Pharmacology of Striatal Neuronal Dysfunction Induced by Mitochondrial Complex I Inhibition
- (2008) C. Costa et al. JOURNAL OF NEUROSCIENCE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started